Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
NASDAQ:RDHL

RedHill Biopharma - RDHL News Today

$0.38
-0.01 (-2.60%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.37
$0.40
50-Day Range
$0.39
$0.70
52-Week Range
$0.25
$3.37
Volume
618,018 shs
Average Volume
1.87 million shs
Market Capitalization
$19.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Get RedHill Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter.



RDHL Media Mentions By Week

RDHL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RDHL
News Sentiment

0.07

0.75

Average
Medical
News Sentiment

RDHL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RDHL Articles
This Week

6

1

RDHL Articles
Average Week

SourceHeadline
MarketBeat logoRedHill Biopharma (RDHL) Scheduled to Post Quarterly Earnings on Monday
americanbankingnews.com - November 27 at 7:38 AM
MarketBeat logoRedHill Biopharma (NASDAQ:RDHL) Earns Hold Rating from Analysts at StockNews.com
americanbankingnews.com - November 27 at 2:32 AM
finance.yahoo.com logoRedHill Says Opaganib Has Potential As Nuclear Radiation Protection For Homeland Security Countermeasures
finance.yahoo.com - November 24 at 9:06 PM
finance.yahoo.com logoThe RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Just Cut Their Revenue Forecast By 23%
finance.yahoo.com - November 24 at 11:03 AM
finance.yahoo.com logoRedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation Injury
finance.yahoo.com - November 17 at 8:40 AM
finance.yahoo.com logoRedHill Biopharma set to lose key revenue source, could 'cease operations'
finance.yahoo.com - November 15 at 4:17 PM
finance.yahoo.com logoRedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published
finance.yahoo.com - November 14 at 8:41 AM
finance.yahoo.com logoRedHill Biopharma Second Quarter 2022 Earnings: Misses Expectations
finance.yahoo.com - November 13 at 5:26 PM
finance.yahoo.com logoRedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
finance.yahoo.com - November 7 at 9:57 AM
finance.yahoo.com logoRedHill Presents New Talicia® Data Analyses at Obesity Week 2022
finance.yahoo.com - November 4 at 8:43 AM
finance.yahoo.com logoRedHill Biopharma Ltd.'s (NASDAQ:RDHL) Path To Profitability
finance.yahoo.com - October 30 at 4:23 PM
finance.yahoo.com logoAfter job cuts, Raleigh drugmaker considers selling lead product
finance.yahoo.com - October 27 at 6:24 PM
finance.yahoo.com logoRedHill Presents New Talicia® and Movantik® Data Analyses at ACG 2022
finance.yahoo.com - October 26 at 8:59 AM
finance.yahoo.com logoRedHill Biopharma (RDHL) Up on New Patent for COVID-19 Candidate
finance.yahoo.com - October 20 at 5:04 PM
finance.yahoo.com logoRedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate
finance.yahoo.com - October 19 at 8:55 PM
markets.businessinsider.com logoRedHill's Oral Antiviral, Opaganib, Granted New COVID-19 Treatment Patent
markets.businessinsider.com - October 19 at 3:55 PM
seekingalpha.com logoRDHL RedHill Biopharma Ltd.
seekingalpha.com - October 19 at 3:55 PM
finance.yahoo.com logoRedHill's Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Patent
finance.yahoo.com - October 19 at 7:27 AM
finance.yahoo.com logoRedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
finance.yahoo.com - October 18 at 9:49 AM
thestreet.com logoRedhill Biopharma Ltd.
thestreet.com - October 11 at 12:30 PM
finance.yahoo.com logoRedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5
finance.yahoo.com - October 11 at 2:29 AM
nasdaq.com logoRedHill Says Its Oral Antivirals, Opaganib And RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5
nasdaq.com - October 3 at 9:13 AM
finance.yahoo.com logoRedHill's Oral Broad-Acting Antivirals, Opaganib and RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5
finance.yahoo.com - October 3 at 9:13 AM
finance.yahoo.com logoRedHill Biopharma Ltd. (RDHL)
finance.yahoo.com - September 20 at 10:18 PM
nasdaq.com logoThe past five years for RedHill Biopharma (NASDAQ:RDHL) investors has not been profitable
nasdaq.com - September 1 at 2:30 AM
finance.yahoo.com logoRedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug
finance.yahoo.com - August 18 at 2:00 PM
finance.yahoo.com logoRedHill Biopharma Shares Pop On European Orphan Tag For Lung Disease Candidate
finance.yahoo.com - August 17 at 5:12 PM
msn.com logoRedHill Shares Gain As European Commission Grants Orphan Drug Status To NTM Infections Candidate
msn.com - August 17 at 12:12 PM
nasdaq.com logoRedHill Biopharma: RHB-204 Gets EU Orphan Drug Designation For NTM Infections
nasdaq.com - August 17 at 12:12 PM
finance.yahoo.com logoRedHill Biopharma Announces EU Orphan Drug Designation for RHB-204 for NTM Infections
finance.yahoo.com - August 17 at 12:12 PM
finance.yahoo.com logoRedHill Biopharma (NASDAQ:RDHL) investors are sitting on a loss of 89% if they invested five years ago
finance.yahoo.com - August 10 at 11:14 AM
finance.yahoo.com logoRedHill Announces New H. pylori and COVID-19 Data Publication and Presentations at Leading Upcoming Scientific Conferences
finance.yahoo.com - July 12 at 11:48 AM
finance.yahoo.com logoRaleigh drugmaker slashes workforce as biotech downturn deepens
finance.yahoo.com - June 24 at 10:01 AM
marketwatch.com logoRedHill Biopharma Shares Rally Premarket on Cash Generation Plans >RDHL
marketwatch.com - June 23 at 6:01 PM
seekingalpha.com logoRedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - June 23 at 6:01 PM
finance.yahoo.com logoRedHill Biopharma Shares Trading Higher On Improved Q1 Profitability
finance.yahoo.com - June 23 at 6:01 PM
finance.yahoo.com logoRedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22
finance.yahoo.com - June 23 at 8:06 AM
finance.yahoo.com logoRedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022
finance.yahoo.com - June 17 at 7:04 PM
finance.yahoo.com logoRedHill Presents New Talicia® Data Analyses at DDW 2022
finance.yahoo.com - May 25 at 12:27 PM
finance.yahoo.com logoRaleigh drugmaker pursuing Covid treatment raising $15M to fund acquisitions
finance.yahoo.com - May 10 at 10:11 AM
seekingalpha.com logoRedHill Biopharma to raise $15M in equity offering
seekingalpha.com - May 9 at 2:21 PM
finance.yahoo.com logoRedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor
finance.yahoo.com - May 9 at 8:39 AM
finance.yahoo.com logoRedHill Biopharma Ltd. (NASDAQ:RDHL): Is Breakeven Near?
finance.yahoo.com - May 4 at 7:46 PM
finance.yahoo.com logoRedhill Biopharma Ltd. (RDHL) Could Find Support Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - April 14 at 3:48 PM
msn.com logoRedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
msn.com - April 14 at 12:51 AM
seekingalpha.com logoRedHill posts lab data to support efficacy of COVID-19 drug against Omicron
seekingalpha.com - April 11 at 7:19 PM
finance.yahoo.com logoRedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro
finance.yahoo.com - April 11 at 7:18 PM
finance.yahoo.com logoRedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
finance.yahoo.com - April 11 at 8:43 AM
markets.businessinsider.com logoWhat Wall Street expects from Redhill Biopharma's earnings
markets.businessinsider.com - March 18 at 3:24 AM
benzinga.com logoRedhill Biopharma: Q4 Earnings Insights
benzinga.com - March 17 at 5:23 PM
Get RedHill Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:RDHL) was last updated on 11/28/2022 by MarketBeat.com Staff